Amgen Inc. announced on Tuesday that its revenue for the third quarter of 2025 stood at $9.6 billion, rising 12% from the same quarter a year earlier.
GAAP net income landed at $3.2 billion, year-over-year, or $5.93 per diluted share. GAAP operating income increased 25% annually to $2.5 billion.
"We delivered strong volume growth this quarter, reflecting the demand for our medicines and the impact we're having on patients worldwide. With disciplined investment and a pipeline of first-in-class medicines, we're focused on expanding access, advancing innovation, and sustaining long-term growth," Chairman and CEO Robert A. Bradway said.
https://breakingthenews.net/Article/Amgen-Q3-revenue-jumps-12-to-dollar9.6-billion/65117481
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.